Thursday, December 8, 2016

David C. Swinney

David C. Swinney is Principal at the Institute for Rare and Neglected Diseases Drug Discovery and previously was Director of Virology Biochemical Pharmacology at Roche, Palo Alto.

Sort By

Commentaries available in 12 Languages